The role of Raf-1 kinase in diabetic retinopathy

Bibliography

• Klein R, Klein BE, Jensen SC, The relation of socioeconomic factors to the incidence of proliferative diabetic retinopathy and loss of vision. Ophthalmology 1994;101:68-76
   PubMed Web of Science ®Google Scholar
• Chew EY. Epidemiology of diabetic retinopathy. Hosp Med 2003;64:396-9
   PubMed Web of Science ®Google Scholar
• Porta M, Bandello F. Diabetic retinopathy: a clinical update. Diabetologia 2002;45:1617-34
   PubMed Web of Science ®Google Scholar
• Frank RN. Diabetic retinopathy. N Engl J Med 2004;350:48-58
   PubMed Web of Science ®Google Scholar
• Diabetes control and complications trial research group. Early worsening of diabetic retinopathy in the diabetes control and complication trial. Arch Ophthalmol 1998;116:874-86
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-53
   PubMed Web of Science ®Google Scholar
• Mizutani M, Gerhardinger C, Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes 1998;47:455-9
   Google Scholar
• Barber AJ, Lieth E, Khin SA, Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783-91
   PubMed Web of Science ®Google Scholar
• Kern TS, Tang J, Mizutani M, Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 2000;41:3972-8
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Odenbach S. Effect of long-term administration of alpha lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 2004;53:3233-8
   PubMed Web of Science ®Google Scholar
• Davis MD, Norton EWD, Myers FL. The Airlie House classification of diabetic retinopathy. In: Goldberg MF, Fine SL, editors, Symposium on the Treatment of Diabetic Retinopathy. US Public Health Service Publishers, 1969; Public Health Service Publication, Washington DC; 1890. p. 7-22
   Google Scholar
• Bresnick GH, Davis MD, Myers FL, Clinicopathologic correlations in diabetic retinopathy. II. Clinical and histologic appearances of retinal capillary microaneurysms. Arch Ophthalmol 1977;95:1215-20
   PubMedGoogle Scholar
• Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes 1989;38:1203-6
   PubMed Web of Science ®Google Scholar
• Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 1996;97:2883-90
   PubMed Web of Science ®Google Scholar
• Joussen AM, Poulaki V, Tsujikawa A, Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol 2002;160:1683-93
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kowluru A, Chakrabarti S, Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats. Diabetes 2004;53:775-83
   PubMedGoogle Scholar
• El-Remessy AB, Bartoli M, Platt DH, Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci 2005;118:243-52
   PubMed Web of Science ®Google Scholar
• Rayappa S, Kowluru RA. Role of Raf-1 kinase in diabetes-induced accelerated apoptosis of retinal capillary cells. Int J Biomed Sci 2008;4:20-8
   PubMedGoogle Scholar
• Du Y, Tang J, Li G, Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function. Invest Ophthalmol Vis Sci 2010;51:2158-64
   PubMed Web of Science ®Google Scholar
• Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 2010;106:1319-31
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kanwar M. Translocation of H-Ras and its implications in the development of diabetic retinopathy. Biochem Biophys Res Commun 2009;387:461-6
   PubMedGoogle Scholar
• Schubbert S, Bollag G, Shannon K. Deregulated Ras signaling in developmental disorders: new tricks for an old dog. Curr Opin Genet Dev 2007;17:15-22
   PubMed Web of Science ®Google Scholar
• Omerovic J, Prior IA. Compartmentalized signaling: ras proteins and signaling nanoclusters. FEBS J 2009;276:1817-25
   PubMed Web of Science ®Google Scholar
• Leicht DT, Balan V, Kaplun A, Raf kinases: function, regulation and role in human cancer. Biochim Biophys Acta 2007;1773:11961212
   Google Scholar
• McCubrey JA, Steelman LS, Abrams SL, Emerging MEK inhibitors. Expert Opin Emerg Drugs 2010;15:203-23
   PubMed Web of Science ®Google Scholar
• Roskoski R. RAF protein-serine/threonine kinases: structure and regulation. Biochem Biophys Res Commun 2010;399:313-17
   PubMed Web of Science ®Google Scholar
• Zhang L, Fu Z, Binkley C, Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery 2004;136:708-15
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang X, Qin X, RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma. Oncogene 2010;295:100-9
   Google Scholar
• Schwieger A, Bauer L, Hanusch J, Ras oncogene expression determines sensitivity for intercellular induction of apoptosis. Carcinogenesis 2001;22:1385-92
   PubMed Web of Science ®Google Scholar
• Kowluru V, Kowluru RA. Increased oxidative stress in diabetes regulates activation of a small molecular weight G-protein, H-Ras, in the retina. Mol Vis 2007;13:602-10
   PubMed Web of Science ®Google Scholar
• Cuda G, Paterno R, Candigliota M, Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling. Circulation 2002;105:968-74
   PubMed Web of Science ®Google Scholar
• Urata Y, Yamaguchi M, Higashiyama Y, Reactive oxygen species accelerate production of vascular endothelial growth factor by advanced glycation end products in RAW264.7 mouse macrophages. Free Radic Biol Med 2002;32:688-701
   PubMedGoogle Scholar
• McCubrey JA, Steelman LS, Chappell WH, Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 2007;1777:1263-84
   Google Scholar
• Gurumurthy RK, Mäurer AP, Machuy N, A loss-of-function screen reveals Ras- and Raf- independent MEK-ERK signaling during Chlamydia trachomatis infection. Sci. Signal 2010;3:ra21
   Google Scholar
• Kanno T, Siebenlist U. Activation of nuclear factor-kappaB via T cell receptor requires a Raf kinase and Ca2+ influx. Functional synergy between Raf and calcineurin. J Immunology 1996;157:5277-83
   PubMedGoogle Scholar
• Sangle GV, Zhao R, Shen GX. Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells. Am J Physiol Endocrinol Metab 2008;295:E1243-54
   Web of Science ®Google Scholar
• Sangle GV, Zhao R, Mizuno TM, Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells. Endocrinology 2010;151:4455-66
   PubMed Web of Science ®Google Scholar
• Kowluru A, Veluthakal R, Rhodes CJ, Protein farnesylation-dependent Raf/extracellular signal-related kinase signaling links to cytoskeletal remodeling to facilitate glucose-induced insulin secretion in pancreatic beta-cells. Diabetes 2010;59:967-77
   PubMed Web of Science ®Google Scholar
• Reece EA, Wu YK, Zhao Z, Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats. Am J Obstet Gynecol 2006;194:580-5
   PubMedGoogle Scholar
• Kowluru RA, Kowluru A, Kanwar M. Small molecular weight G-protein, H-Ras, and retinal endothelial cell apoptosis in diabetes. Mol Cell Biochem 2007;296:69-76
   PubMed Web of Science ®Google Scholar
• Kanwar M, Chan PS, Kern TS, Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 2007;48:3805-11
   PubMed Web of Science ®Google Scholar
• Kanwar M, Kowluru RA. Diabetes regulates small molecular weight G-protein, H-Ras, in the microvasculature of the retina: Implication in the development of retinopathy. Microvasc Res 2008;76:189-93
   PubMedGoogle Scholar
• Aiello LP. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res 1997;29:354-62
   PubMed Web of Science ®Google Scholar
• Gulbins E, Coggeshall KM, Brenner B, Fas-induced apoptosis is mediated by activation of a Ras and Rac protein-regulated signaling pathway. J Biol Chem 1996;271:26389-94
   PubMedGoogle Scholar
• Moorman JP, Gilmer L, Hahn CS, Inactivation of the small G-protein disrupts cellular adhesion and spreading and activates apoptosis. J Inves Med 1996;44:240A
   Google Scholar
• Wang CH, Tsai LJ, Tsao YP, Recombinant adenovirus encoding H-ras ribozyme induces apoptosis in laryngeal cancer cells through caspase- and mitochondria-dependent pathways. Biochem Biophys Res Commun 2002;298:805-14
   PubMedGoogle Scholar
• Klein C, Creach K, Irintcheva V, Zinc induces ERK-dependent cell death through a specific Ras isoform. Apoptosis 2006;11:1933-44
   PubMedGoogle Scholar
• Zhao Y, Chaiswing L, Bakthavatchalu V, Ras mutation promotes p53 activation and apoptosis of skin keratinocytes. Carcinogenesis 2006;27:1692-8
   PubMedGoogle Scholar
• Singh M, Sharma H, Singh N. Hydrogen peroxide induces apoptosis in HeLa cells through mitochondrial pathway. Mitochondrion 2007;7:367-73
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Abbas SN. Diabetes-induced mitochondrial dysfunction in the retina. Inves Ophthalmol Vis Sci 2003;44:5327-34
   PubMed Web of Science ®Google Scholar
• Zhu L, Yu X, Akatsuka Y, Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells. Immunology 1999;97:26-35
   PubMedGoogle Scholar
• Nguyen TT, Tran E, Nguyen TH, The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 2004;25:647-59
   PubMed Web of Science ®Google Scholar
• Wang X, Martindale JL, Holbrook NJ. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 2004;275:39435-43
   Google Scholar
• Ramos JW. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol 2008;40:2707-19
   PubMed Web of Science ®Google Scholar
• Li AF, Roy S. High glucose-induced downregulation of connexin 43 expression promotes apoptosis in microvascular endothelial cells. Invest Ophthalmol Vis Sci 2009;50:1400-7
   PubMedGoogle Scholar
• Narasimhan P, Liu J, Song YS, VEGF Stimulates the ERK 1/2 signaling pathway and apoptosis in cerebral endothelial cells after ischemic conditions. Stroke 2009;40:1467-73
   PubMed Web of Science ®Google Scholar
• Romeo G, Liu WH, Asnaghi V, Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 2002;51:2241-8
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Koppolu P, Chakrabarti S, Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Research 2003;37:1169-80
   PubMed Web of Science ®Google Scholar
• Zheng L, Szabo C, Kern TS. Poly (ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 2004;53:2960-7
   PubMed Web of Science ®Google Scholar
• Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007;2007:95103
   PubMed Web of Science ®Google Scholar
• Moreno-Aspitia A. Clinical overview of sorafenib in breast cancer. Future Oncol 2010;6:655-63
   PubMedGoogle Scholar
• Michaelis M, Paulus C, Löschmann N, The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication. Cell Mol Life Sci 2010: published online 30 August 2010, doi: 10.1007/s00018-010-0510-8
   Google Scholar
• Oza AM, Elit L, Swenerton K, NCIC Clinical trials group study (NCIC IND.116). Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116). Gynecol Oncol 2003;89:129-33
   PubMed Web of Science ®Google Scholar
• Jardeleza MS, Miller JW. Review of anti-VEGF therapy in proliferative diabetic retinopathy. Semin Ophthalmol 2010;24:87-92
   Google Scholar
• Hnik P, Boyer DS, Grillone LR, Antisense oligonucleotide therapy in diabetic retinopathy. J Diabetes Sci Technol 2009;3:924-30
   PubMedGoogle Scholar
• Sudhakar A, Nyberg P, Keshamouni VG, Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin. J Clin Invest 2005;115:2801-10
   PubMed Web of Science ®Google Scholar
• Potenza MA, Gagliardi S, Nacci C, Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 2009;16:94-112
   PubMed Web of Science ®Google Scholar
• Gu W, Putral LN, Irving A, The development and future of oligonucleotide-based therapies for cervical cancer. Curr Opin Mol Ther 2007;9:126-31
   PubMedGoogle Scholar
• Holtmann MH, Neurath MF. From immunogenic mechanisms to novel therapeutic approaches in inflammatory bowel disease. Adv Exp Med Biol 2006;579:227-42
   PubMed Web of Science ®Google Scholar
• Danis RP, Henry SP, Ciulla TA. Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases. Exp Opin Pharmacotherapy 2001;2:277-91
   PubMedGoogle Scholar
• Yamamot H. Mechanisms of vascular injury in diabetes: lessons from vascular cells in culture and transgenic animals. Biomed Rev 2000;11:19-27
   Google Scholar
• Helene C. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides. Eur J Cancer 1991;27:1466-71
   PubMed Web of Science ®Google Scholar
• Roy S, Sato T, Paryani G, Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes 2003;52:1229-34
   PubMed Web of Science ®Google Scholar
• Wilkinson-Berka JL, Wraight C, Werther G. The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy. Curr Med Chem 2006;13:3307-17
   PubMed Web of Science ®Google Scholar
• Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993;16:642-52
   PubMed Web of Science ®Google Scholar